Victoria Ly, MD, MPH, explains potential next steps for her research on vision screening follow-up rate disparities among children in Arkansas.
A literature review revealed cost was a barrier inhibiting some parents from seeking follow-up eye care for their children after a failed vision screening test, said Victoria Ly, MD, MPH, an intern resident physician at University of Texas Southwestern Medical Center in ophthalmology.
Transcript:
Would efforts to increase Children's Health Insurance Program (CHIP) enrollment help close the gap in vision screening follow-up disparities?
In my opinion, I think my study cannot exactly say that for sure. My study just determined association, not necessarily causation. But in my literature review, there were some studies that showed that parents found that the perceived barriers included affording care. So it's very possible that increasing CHIP enrollment could close the gap in the follow-up eye care for kids.
What are the next steps for your research?
The next steps I think more appropriately would be to expand the project to a more longitudinal study. It could follow a cohort of students who had failed their school vision screening, and then to wrap up the project, possibly implementing a survey that's given to the parents of those students. They could report their demographics, socioeconomic background, [and] what they perceive as barriers for their eye care. Then that could help direct what, hopefully, our public health leaders will look at so that they can improve accessibility for children who need better eye care. As far as investigating the rates in other states, I did move from Arkansas to Texas for my residency, and there is a Texas mandate for school vision screenings, so it's on the drawing board for potential studies that I could pick up later in the future.
BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer
January 15th 2025The Breast Cancer Index (BCI) may help identify patients with low-risk breast cancer who could potentially benefit from reduced endocrine therapy, leading to improved quality of life and potentially lower health care costs.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Designing Care for the Underserved Creates Higher-Value Health Solutions
January 12th 2025In the second half of our interview with Brita Roy, MD, MPH, MHS, NYU Grossman School of Medicine, she discusses effective engagement of minoritized populations in discussion of medical mistrust.
Read More
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More